Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Next Tech 3 New Technology Investment Fund | SMR NUSCALE POWER Corp | 13G/A | 3.4% | Dec 31, 2023 | 2y |
| GOLDMAN SACHS GROUP INC | QBTS D-Wave Quantum Inc. | 13G/A | 7% | Dec 29, 2023 | 2y |
| Bhat Laxminarayan | RVPH Reviva Pharmaceuticals Holdings, Inc. | 13D/A | 10.2% | Nov 20, 2023 | 2y |
| 3DOM Alliance Inc. | NCNC noco-noco Inc. Ordinary Share | 13G | 66.9% | Aug 28, 2023 | 2y |
| Funicular Funds, LP | SYBX Synlogic, Inc. | 13D | 36% | Feb 9, 2023 | 2y |
| Board of Directors of MetLife, Inc., as an entity | MET Metlife Inc | 13D/A | 16.2% | Feb 15, 2024 | 2y |
| Michael Moore | VMD Viemed Healthcare, Inc. | 13D/A | 6.5% | Feb 15, 2024 | 2y |
| Radoff Bradley Louis | LFVN Lifevantage Corp | 13D/A | 6.7% | Feb 14, 2024 | 2y |
| STILWELL JOSEPH | SFBC Sound Financial Bancorp, Inc. | 13D/A | 16.1% | Feb 14, 2024 | 2y |
| Dayton Judd | LFVN Lifevantage Corp | 13D/A | 5.9% | Feb 14, 2024 | 2y |
| GAMCO INVESTORS, INC. ET AL | RUSHA Rush Enterprises Inc Tx | 13D/A | 6.77% | Feb 14, 2024 | 2y |
| Starboard Value LP | ACTG Acacia Research Corp | 13D/A | 61.2% | Feb 13, 2024 | 2y |
| ALSTODT LANCE | BRTX BioRestorative Therapies, Inc. | 13D/A | 11.2% | Feb 13, 2024 | 2y |
| Deerfield Management Company, L.P. | LRMR Larimar Therapeutics, Inc. | 13D/A | 39.2% | Feb 13, 2024 | 2y |
| Christopher Scott Ginieczki, as Personal Representative of the Estate of Geoffrey S. M. Hedrick | IA Innovative Solutions & Support Inc | 13D/A | 7.24% | Feb 13, 2024 | 2y |
| Silva, Francisco | BRTX BioRestorative Therapies, Inc. | 13D/A | 10.7% | Feb 13, 2024 | 2y |
| TCG Crossover GP II, LLC | MLYS Mineralys Therapeutics, Inc. | 13G | 6.4% | Feb 12, 2024 | 2y |
| Lind Global Fund II LP | THC Tenet Healthcare Corp | 13G | 9.9% | Feb 12, 2024 | 2y |
| Mostafa Kandil | SWVL Swvl Holdings Corp | 13D/A | 26.7% | Feb 12, 2024 | 2y |
| Emilio Fernando Azcarraga Jean | TV Grupo Televisa, S.A.B. | 13D/A | 49.67% | Feb 12, 2024 | 2y |
| Millennium Management LLC | BBOT BridgeBio Oncology Therapeutics, Inc. | 13G | 5.8% | Feb 9, 2024 | 2y |
| GIC Private Ltd | TBBB Bbb Foods Inc | 13G | 8.08% | Feb 9, 2024 | 2y |
| ANTA Sports Products Limited | AS Amer Sports, Inc. | 13D | 46% | Feb 8, 2024 | 2y |
| ROSENFELD ERIC | LEGT Legato Merger Corp. III | 13D | 7.2% | Feb 8, 2024 | 2y |
| Phoenix Financial Ltd. | TSEM Tower Semiconductor Ltd | 13G/A | 4.94% | Feb 8, 2024 | 2y |
| FountainVest China Capital Partners GP3 Ltd. | AS Amer Sports, Inc. | 13D | 13.7% | Feb 8, 2024 | 2y |
| Dennis J. Wilson | AS Amer Sports, Inc. | 13D | 20.6% | Feb 8, 2024 | 2y |
| Iroquois Capital Management, LLC | PRSO Peraso Inc. | 13G | 9.99% | Feb 6, 2024 | 2y |
| D. E. Shaw & Co., L.P. | CHGG Chegg, Inc | 13G | 5.5% | Feb 5, 2024 | 2y |
| STRS OHIO | GBDC GOLUB CAPITAL BDC, Inc. | 13G/A | 4.1% | Jan 31, 2024 | 2y |
| KLEMP WALTER V | AMIX Autonomix Medical, Inc. | 13D | 16% | Jan 26, 2024 | 2y |
| Bowen Holding LP | BOWN Bowen Acquisition Corp Ordinary Shares | 13D | 6.2% | Jan 18, 2024 | 2y |
| Createcharm Holdings Ltd. | BOWN Bowen Acquisition Corp Ordinary Shares | 13D | 16.3% | Jan 18, 2024 | 2y |
| EcoR1 Capital, LLC | MORF Morphic Holding, Inc. Common Stock | 13G/A | 0.4% | Dec 31, 2023 | 2y |
| No Street GP LP | FNKO Funko, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Think Investments LP | TASK TaskUs, Inc. | 13G | 7.6% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | SVII Spring Valley Acquisition Corp. II Class A Ordinary Shares | 13G | 9.72% | Dec 31, 2023 | 2y |
| Red Oak Partners, LLC | JETMF Global Crossing Airlines Group Inc. | 13G/A | 9.4% | Dec 31, 2023 | 2y |
| Nortye International Limited | ANL Adlai Nortye Group Ltd. | 13G | 5.4% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | SEDA SDCL EDGE Acquisition Corporation | 13G | 9.95% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | SKGR SK Growth Opportunities Corporation Class A Common Stock | 13G | 6.46% | Dec 31, 2023 | 2y |
| Rosalind Advisors, Inc. | MYO Myomo, Inc. | 13G/A | 9.2% | Dec 31, 2023 | 2y |
| Yi ZHANG | LSBWF LakeShore Biopharma Co., Ltd. | 13G | 42.6% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | TRTL TortoiseEcofin Acquisition Corp. III | 13G | 9.82% | Dec 31, 2023 | 2y |
| Innovation Endeavors II, L.P. | BMR Beamr Imaging Ltd. | 13G | 8% | Dec 31, 2023 | 2y |
| Ronald F. Clarke | CPAY Corpay, Inc. | 13G | 5.6% | Dec 31, 2023 | 2y |
| John P. D. Cato | CATO Cato Corp | 13G/A | 14.5% | Dec 31, 2023 | 2y |
| EcoR1 Capital, LLC | AVIR Atea Pharmaceuticals, Inc. | 13G/A | 8.4% | Dec 31, 2023 | 2y |
| PRINCIPAL FINANCIAL GROUP INC | BCOW 1895 Bancorp of Wisconsin, Inc. | 13G/A | 9.38% | Dec 31, 2023 | 2y |
| Nortye Talent Limited | ANL Adlai Nortye Group Ltd. | 13G | 8.1% | Dec 31, 2023 | 2y |